68 related articles for article (PubMed ID: 11009090)
1. Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivo.
Esche C; Cai Q; Peron JM; Hunter O; Subbotin VM; Lotze MT; Shurin MR
Eur J Immunol; 2000 Sep; 30(9):2565-75. PubMed ID: 11009090
[TBL] [Abstract][Full Text] [Related]
2. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
[TBL] [Abstract][Full Text] [Related]
3. FLT3 ligand induces the generation of functionally active dendritic cells in mice.
Shurin MR; Pandharipande PP; Zorina TD; Haluszczak C; Subbotin VM; Hunter O; Brumfield A; Storkus WJ; Maraskovsky E; Lotze MT
Cell Immunol; 1997 Aug; 179(2):174-84. PubMed ID: 9268501
[TBL] [Abstract][Full Text] [Related]
4. FLT3-ligand administration inhibits liver metastases: role of NK cells.
Péron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
6. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo.
Lau AH; Abe M; Thomson AW
J Leukoc Biol; 2006 May; 79(5):941-53. PubMed ID: 16478920
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness.
Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M
Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735
[TBL] [Abstract][Full Text] [Related]
8. Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-alpha production.
Vollstedt S; O'Keeffe M; Odermatt B; Beat R; Glanzmann B; Riesen M; Shortman K; Suter M
Eur J Immunol; 2004 Jul; 34(7):1849-60. PubMed ID: 15214033
[TBL] [Abstract][Full Text] [Related]
9. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
10. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
12. Flt3-ligand-mobilized peripheral blood, but not Flt3-ligand-expanded bone marrow, facilitating cells promote establishment of chimerism and tolerance.
Huang Y; Kucia M; Rezzoug F; Ratajczak J; Tanner MK; Ratajczak MZ; Schanie CL; Xu H; Fugier-Vivier I; Ildstad ST
Stem Cells; 2006 Apr; 24(4):936-48. PubMed ID: 16644924
[TBL] [Abstract][Full Text] [Related]
13. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
[TBL] [Abstract][Full Text] [Related]
15. Disease-modifying capability of murine Flt3-ligand DCs in experimental autoimmune encephalomyelitis.
Papenfuss TL; Kithcart AP; Powell ND; McClain MA; Gienapp IE; Shawler TM; Whitacre CC
J Leukoc Biol; 2007 Dec; 82(6):1510-8. PubMed ID: 17855499
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligand.
Esche C; Subbotin VM; Hunter O; Peron JM; Maliszewski C; Lotze MT; Shurin MR
J Invest Dermatol; 1999 Dec; 113(6):1028-32. PubMed ID: 10594747
[TBL] [Abstract][Full Text] [Related]
17. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.
Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
Cancer Res; 1998 Feb; 58(3):380-3. PubMed ID: 9458075
[TBL] [Abstract][Full Text] [Related]
18. Effect of pimecrolimus vs. corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation and function.
Krummen MB; Varga G; Steinert M; Stuetz A; Luger TA; Grabbe S
Exp Dermatol; 2006 Jan; 15(1):43-50. PubMed ID: 16364030
[TBL] [Abstract][Full Text] [Related]
19. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
Wells JW; Darling D; Farzaneh F; Galea-Lauri J
Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
[TBL] [Abstract][Full Text] [Related]
20. Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand.
Shurin GV; Chatta GS; Tourkova IL; Zorina TD; Esche C; Shurin MR
Exp Gerontol; 2004 Mar; 39(3):339-48. PubMed ID: 15036393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
